Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis

Inflammatory Bowel Diseases

Volumn 17, Issue 11, 2011, Pages 2287-2294

  Diaz Gallo, Lina Marcela ^a   Espino Paisán, Laura ^b   Fransen, Karin ^c   Gõmez García, María ^d   Van Sommeren, Suzanne ^c   Cardeña, Carlos ^e   Rodrigo, Luis ^f   Mendoza, Juan Luis ^b   Taxonera, Carlos ^b   Nieto, Antonio ^g   Alcain, Guillermo ^h   Cueto, Ignacio ^h   Lõpez Nevot, Miguel A ^d   Bottini, Nunzio ⁱ   Barclay, Murray L ^j   Crusius, J Bart ^k   Van Bodegraven, Adriaan A ^k   Wijmenga, Cisca ^c   Ponsioen, Cyriel Y ^k   Gearry, Richard B ^j   Roberts, Rebecca L ^l   Weersma, Rinse K ^c   Urcelay, Elena ^b   Merriman, Tony R ^l   Alizadeh, Behrooz Z ^c   Martin, Javier ^a   more..

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^e HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^f HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^g HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^h HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

ⁱ LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^j UNIVERSITY OF OTAGO   (New Zealand)

^k ACADEMIC MEDICAL CENTER   (Netherlands)

^l UNIVERSITY OF OTAGO   (New Zealand)

more..

Author keywords

Crohn's disease (CD); inflammatory bowel disease (IBD); nonreceptor type 22 (PTPN22) gene; protein tyrosine phosphatase; ulcerative colitis (UC)

Indexed keywords

ALLELE; ARTICLE; AUTOIMMUNITY; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; NEW ZEALAND; PRIORITY JOURNAL; PTPN22 GENE; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; ULCERATIVE COLITIS;

CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; NEW ZEALAND; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; RISK FACTORS; SPAIN;

EID: 80052971255     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21630     Document Type: Article

References (55)

1. Baumgart DC, Carding SR,. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007; 369: 1627-1640. (Pubitemid 46722636)
2. Budarf ML, Labbe C, David G, et al. GWA studies: rewriting the story of IBD. Trends Genet. 2009; 25: 137-146.
3. Kaser A, Zeissig S, Blumberg RS,. Inflammatory bowel disease. Annu Rev. Immunol. 2010; 28: 573-621.
4. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature. 2009; 461: 747-753.
5. Cloutier JF, Veillette A,. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med. 1999; 189: 111-121. (Pubitemid 29047031)
6. Stanford SM, Mustelin TM, Bottini N,. Lymphoid tyrosine phosphatase and autoimmunity: human genetics rediscovers tyrosine phosphatases. Semin Immunopathol. 2010; 32: 127-36.
7. Wu J, Katrekar A, Honigberg LA, et al. Identification of substrates of human protein-tyrosine phosphatase PTPN22. J Biol Chem. 2006; 281: 11002-11010. (Pubitemid 43855523)
8. Yu X, Sun JP, He Y, et al. Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases. Proc Natl Acad Sci U S A. 2007; 104: 19767-19772.
9. Arechiga AF, Habib T, He Y, et al. Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. J Immunol. 2009; 182: 3343-3347.
10. Bottini N, Musumeci L, Alonso A, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet. 2004; 36: 337-338. (Pubitemid 38437254)
11. Liu Y, Stanford SM, Jog SP, et al. Regulation of lymphoid tyrosine phosphatase activity: inhibition of the catalytic domain by the proximal interdomain. Biochemistry. 2009; 48: 7525-7532.
12. Orru V, Tsai SJ, Rueda B, et al. A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus. Hum Mol Genet. 2009; 18: 569-579.
13. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008; 40: 955-962.
14. Bottini N, Vang T, Cucca F, et al. Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin Immunol. 2006; 18: 207-213. (Pubitemid 43903283)
15. Gregersen PK, Lee HS, Batliwalla F, et al. PTPN22: setting thresholds for autoimmunity. Semin Immunol. 2006; 18: 214-223. (Pubitemid 43903284)
16. Lee YH, Rho YH, Choi SJ, et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases-a meta-analysis. Rheumatology (Oxford). 2007; 46: 49-56. (Pubitemid 44932783)
17. Fiorillo E, Orru V, Stanford SM, et al. Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue. J Biol Chem. 2010; 285: 26506-25618.
18. Rodriguez-Rodriguez L, Wan Taib WR, Topless R, et al. The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples. Arthritis Rheum. 2010, Nov 15. [Epub ahead of print].
19. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000; 6: 8-15.
20. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006; 55: 749-753. (Pubitemid 43764536)
21. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005; 19 (suppl A): 5-36.
22. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007; 81: 559-575. (Pubitemid 47330214)
23. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007; 447: 661-678.
24. Anderson CA, Massey DC, Barrett JC, et al. Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology. 2009; 136: 523-529 e523.
25. De Jager PL, Sawcer S, Waliszewska A, et al. Evaluating the role of the 620W allele of protein tyrosine phosphatase PTPN22 in Crohn's disease and multiple sclerosis. Eur J Hum Genet. 2006; 14: 317-321.
26. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006; 314: 1461-1463. (Pubitemid 44871953)
27. Franke A, Balschun T, Karlsen TH, et al. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet. 2008; 40: 713-715. (Pubitemid 351748866)
28. Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet. 2007; 39: 207-211. (Pubitemid 46184351)
29. Hradsky O, Lenicek M, Dusatkova P, et al. Variants of CARD15, TNFA and PTPN22 and susceptibility to Crohn's disease in the Czech population: high frequency of the CARD15 1007fs. Tissue Antigens. 2008; 71: 538-547. (Pubitemid 351697250)
30. Latiano A, Palmieri O, Valvano MR, et al. Evaluating the role of the genetic variations of PTPN22, NFKB1, and FcGRIIIA genes in inflammatory bowel disease: a meta-analysis. Inflamm Bowel Dis. 2007; 13: 1212-1219. (Pubitemid 47603099)
31. Lettre G, Rioux JD,. Autoimmune diseases: insights from genome-wide association studies. Hum Mol Genet. 2008; 17: R116-121.
32. Libioulle C, Louis E, Hansoul S, et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 2007; 3: e58.
33. Martin MC, Oliver J, Urcelay E, et al. The functional genetic variation in the PTPN22 gene has a negligible effect on the susceptibility to develop inflammatory bowel disease. Tissue Antigens. 2005; 66: 314-317. (Pubitemid 41406669)
34. Massey DC, Parkes M,. Genome-wide association scanning highlights two autophagy genes, ATG16L1 and IRGM, as being significantly associated with Crohn's disease. Autophagy. 2007; 3: 649-651. (Pubitemid 350060072)
35. Mathew CG,. New links to the pathogenesis of Crohn disease provided by genome-wide association scans. Nat Rev Genet. 2008; 9: 9-14. (Pubitemid 350277296)
36. Parkes M, Barrett JC, Prescott NJ, et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet. 2007; 39: 830-832. (Pubitemid 47014496)
37. Prescott NJ, Fisher SA, Onnie C, et al. A general autoimmunity gene (PTPN22) is not associated with inflammatory bowel disease in a British population. Tissue Antigens. 2005; 66: 318-320. (Pubitemid 41406670)
38. Raelson JV, Little RD, Ruether A, et al. Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci. Proc Natl Acad Sci U S A. 2007; 104: 14747-14752. (Pubitemid 350003214)
39. Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet. 2007; 39: 596-604. (Pubitemid 46676115)
40. Silverberg MS, Cho JH, Rioux JD, et al. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet. 2009; 41: 216-220.
41. Torkamani A, Topol EJ, Schork NJ,. Pathway analysis of seven common diseases assessed by genome-wide association. Genomics. 2008; 92: 265-272.
42. van Oene M, Wintle RF, Liu X, et al. Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations. Arthritis Rheum. 2005; 52: 1993-1998. (Pubitemid 40994320)
43. Wagenleiter SE, Klein W, Griga T, et al. A case-control study of tyrosine phosphatase (PTPN22) confirms the lack of association with Crohn's disease. Int J Immunogenet. 2005; 32: 323-324. (Pubitemid 41392378)
44. Yamazaki K, McGovern D, Ragoussis J, et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet. 2005; 14: 3499-3506. (Pubitemid 41672132)
45. McGovern DP, Gardet A, Torkvist L, et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet. 2010; 42: 332-337.
46. Wang K, Baldassano R, Zhang H, et al. Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. Hum Mol Genet. 2010; 19: 2059-67.
47. Morgan AR, Han DY, Huebner C, et al. PTPN2 but not PTPN22 is associated with Crohn's disease in a New Zealand population. Tissue Antigens. 2010; 76: 119-125.
48. Rose NR,. Predictors of autoimmune disease: autoantibodies and beyond. Autoimmunity. 2008; 41: 419-428.
49. Chatenoud L,. CD3-specific antibodies as promising tools to aim at immune tolerance in the clinic. Int Rev Immunol. 2006; 25: 215-233. (Pubitemid 44034581)
50. Behr MA, Divangahi M, Lalande JD,. What's in a name? The (mis)labelling of Crohn's as an autoimmune disease. Lancet. 2010; 376: 202-203.
51. Gomez LM, Anaya JM, Martin J,. Genetic influence of PTPN22 R620W polymorphism in tuberculosis. Hum Immunol. 2005; 66: 1242-1247. (Pubitemid 44294628)
52. Lamsyah H, Rueda B, Baassi L, et al. Association of PTPN22 gene functional variants with development of pulmonary tuberculosis in Moroccan population. Tissue Antigens. 2009; 74: 228-232.
53. Dean M, Carrington M, O'Brien SJ,. Balanced polymorphism selected by genetic versus infectious human disease. Annu Rev Genomics Hum Genet. 2002; 3: 263-292. (Pubitemid 35217438)
54. Brant SR,. Exposed: the genetic underpinnings of ulcerative colitis relative to Crohn's disease. Gastroenterology. 2009; 136: 396-399.
55. Diaz-Gallo LM, Palomino-Morales RJ, Gomez-Garcia M, et al. STAT4 gene influences genetic predisposition to ulcerative colitis but not Crohn's disease in the Spanish population: a replication study. Hum Immunol. 2010; 71: 515-519.